Bladder Cancer: From the Editor
Bladder Cancer Advances in 2020 and 2021
Let’s Keep the Momentum Going
From the Desk of the Editor
After decades of relative stagnation our field is moving at a dizzying pace toward meaningful improvements in patient care for those suffering from this disease. From better understanding of variant histology, knowledge of the genetic profile of tumors, identification of key signaling pathways, advances in immunotherapy, the adoption of enhanced recover pathways, and more, we now have the tools to make truly meaningful improvements in our patients’ outcomes.